Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MILO: GDF-MRI for Ovarian Cancer Lymph Nodes
NCT02243059Phase 4Withdrawn
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadofosveset in ovarian cancer, sponsored by Maastricht University Medical Center+. Planned start Sep 2014; status: withdrawn.
02
Drugs
gadofosveset
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02243059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243059.